Detection of survivin mRNA in healthy oral mucosa, oral leucoplakia and oral cancer

Oral Diseases

Volumn 16, Issue 1, 2010, Pages 61-67

  Lodi, G ^a   Franchini, R ^a,b   Bez, C ^a   Sardella, A ^a   Moneghini, L ^a   Pellegrini, C ^a   Bosari, S ^a   Manfredi, M ^c   Vescovi, P ^c   Carrassi, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Leucoplakia; Oral; Oral cancer; Potentially malignant lesions; Survivin

Indexed keywords

MESSENGER RNA; SURVIVIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KRUSKAL WALLIS TEST; LEUKOPLAKIA; MALE; MOUTH CANCER; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SMOKING; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 73649126840     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2009.01614.x     Document Type: Article

References (54)

1. Adida C, Recher C, Raffoux E et al (2000). Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol 111 : 196 203. (Pubitemid 30832451)
2. Ambrosini G, Adida C, Altieri DC (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3 : 917 921.
3. Andersen MH, Thor SP (2002). Survivin - a universal tumor antigen. Histol Histopathol 17 : 669 675.
4. Axell T, Pindborg JJ, Smith CJ, van der Waal I (1996). Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994 International Collaborative Group on Oral White Lesions. J Oral Pathol Med 25 : 49 54.
5. Badran A, Yoshida A, Wano Y et al (2003). Expression of the antiapoptotic gene survivin in chronic myeloid leukemia. Anticancer Res 23 : 589 592.
6. Campisi G, Di Fede O, Giovannelli L et al (2005). Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions. Oral Oncol 41 : 994 1004.
7. Chen J, Wu W, Tahir SK et al (2000). Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia 2 : 235 241.
8. Engels K, Knauer SK, Metzler D et al (2007). Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker. J Pathol 211 : 532 540.
9. Falleni M, Pellegrini C, Marchetti A et al (2003). Survivin gene expression in early-stage non-small cell lung cancer. J Pathol 200 : 620 626.
10. Fortugno P, Wall NR, Giodini A et al (2002). Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 115 : 575 585.
11. Freier K, Pungs S, Sticht C et al (2007). High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy. Int J Cancer 120 : 942 946.
12. Fukuda S, Pelus LM (2006). Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 5 : 1087 1098.
13. Gazzaniga P, Gradilone A, Giuliani L et al (2003). Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 14 : 85 90.
14. Grabowski P, Scherubl H (2003). Survivin - an anti-apoptosis protein. Med Sci Monit 9 : LE25.
15. Grossman D, Kim PJ, Blanc-Brude OP et al (2001). Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J Clin Invest 108 : 991 999.
16. Ikeguchi M, Kaibara N (2002). survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma. Br J Cancer 87 : 883 887. (Pubitemid 35252964)
17. Jane C, Nerurkar AV, Shirsat NV, Deshpande RB, Amrapurkar AD, Karjodkar FR (2006). Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers. J Oral Pathol Med 35 : 595 601.
18. Jiang X, Wilford C, Duensing S, Munger K, Jones G, Jones D (2001). Participation of Survivin in mitotic and apoptotic activities of normal and tumor-derived cells. J Cell Biochem 83 : 342 354.
19. Kajiwara Y, Yamasaki F, Hama S et al (2003). Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer 97 : 1077 1083.
20. Kamihira S, Yamada Y, Hirakata Y et al (2001). Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis. Br J Haematol 114 : 63 69.
21. Kappler M, Kohler T, Kampf C et al (2001). Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer 95 : 360 363.
22. Kato J, Kuwabara Y, Mitani M et al (2001). Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95 : 92 95.
23. Kim MJ, Lim KY, Kim JW, Nam IW, Lee JH, Myoung H (2005). Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma. Cancer Lett 224 : 253 261.
24. Koch CA, Vortmeyer AO, Diallo R et al (2002). Survivin: a novel neuroendocrine marker for pheochromocytoma. Eur J Endocrinol 146 : 381 388.
25. Kuttler F, Valnet-Rabier MB, Angonin R et al (2002). Relationship between expression of genes involved in cell cycle control and apoptosis in diffuse large B cell lymphoma: a preferential survivin-cyclin B link. Leukemia 16 : 726 735.
26. Lechler P, Wu X, Bernhardt W et al (2007). The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. Am J Pathol 171 : 1483 1498.
27. Li F, Altieri DC (1999). Transcriptional analysis of human survivin gene expression. Biochem J 344 : 305 311.
28. Li F, Brattain MG (2006). Role of the Survivin gene in pathophysiology. Am J Pathol 169 : 1 11.
29. Li F, Ling X (2006). Survivin study: an update of "what is the next wave"? J Cell Physiol 208 : 476 486.
30. Li F, Ambrosini G, Chu EY et al (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 : 580 584.
31. Lin CY, Hung HC, Kuo RC, Chiang CP, Kuo MY (2005). Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. Oral Oncol 41 : 645 654.
32. Liu YM, Huang JH, Feng DY, Guo XC (2005). [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma]. Ai Zheng 24 : 1354 1357.
33. Lo Muzio L, Staibano S, Pannone G et al (2001). Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 70 : 249 254.
34. Lo Muzio L, Pannone G, Leonardi R et al (2003a). Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 82 : 923 928.
35. Lo Muzio L, Pannone G, Staibano S et al (2003b). Survivin expression in oral squamous cell carcinoma. Br J Cancer 89 : 2244 2248.
36. Lo Muzio L, Campisi G, Giovannelli L et al (2004). HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol 40 : 736 741.
37. Lo Muzio L, D'Angelo M, Procaccini M et al (2005a). Expression of cell cycle markers and human papillomavirus infection in oral squamous cell carcinoma: use of fuzzy neural networks. Int J Cancer 115 : 717 723.
38. Lo Muzio L, Farina A, Rubini C et al (2005b). Survivin as prognostic factor in squamous cell carcinoma of the oral cavity. Cancer Lett 225 : 27 33. (Pubitemid 40732765)
39. Marioni G, Bedogni A, Giacomelli L et al (2005). Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas. Acta Otolaryngol 125 : 1218 1223.
40. Mesri M, Morales-Ruiz M, Ackermann EJ et al (2001). Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol 158 : 1757 1765.
41. O'Connor DS, Grossman D, Plescia J et al (2000). Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 97 : 13103 13107.
42. Pennati M, Colella G, Folini M, Citti L, Daidone MG, Zaffaroni N (2002). Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. J Clin Invest 109 : 285 286.
43. Salvesen GS, Duckett CS (2002). IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3 : 401 410.
44. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ (2000). Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46 : 645 650.
45. Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A, Shimosegawa T (2001). Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 92 : 271 278.
46. Schwartz J, Pinilla-Ibarz J, Yuan RR, Scheinberg DA (2003). Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia. Semin Hematol 40 : 87 96.
47. Tamm I, Wang Y, Sausville E et al (1998). IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58 : 5315 5320.
48. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N (2000). Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6 : 127 134.
49. Tanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H, Tanzawa H (2003). Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 82 : 607 611.
50. Vandesompele J, De Preter K, Pattyn F et al (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 : RESEARCH0034.
51. Weinman EC, Roche PC, Kasperbauer JL et al (2003). Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma. Cancer 97 : 2203 2211.
52. Wurl P, Kappler M, Meye A et al (2002). Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma. Lancet 359 : 943 945.
53. Yagihashi A, Asanuma K, Nakamura M et al (2001). Detection of anti-survivin antibody in gastrointestinal cancer patients. Clin Chem 47 : 1729 1731.
54. Zaffaroni N, Pennati M, Colella G et al (2002). Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol Life Sci 59 : 1406 1412.